
Costa Mesa, CA (February 13, 2026) — The U.S. Food and Drug Administration (FDA) has announced that Green Lumber Holding, LLC is recalling a counterfeit version of its dietary supplement after testing detected the presence of undeclared tadalafil, a prescription-only drug not listed on the label.
The FDA said the affected products were falsely marketed as genuine Green Lumber supplements and pose serious health risks, especially for consumers taking heart or blood pressure medications. Regulators said the updated notice clarifies the specific lot number associated with the counterfeit product and reiterates consumer safety guidance.
Green Lumber recall: quick summary
The recall covers counterfeit dietary supplements labeled as Green Lumber products that contain tadalafil, an undeclared prescription drug. The FDA confirmed the issue through testing and published the enforcement action on February 13, 2026, referencing a recall that began in August 2025. Only one lot number is affected, and the recall does not include legitimate Green Lumber products with other lot codes. Regulators urge consumers to stop using the recalled product immediately and report any adverse events.
Official recall details
✦
Recall date: February 13, 2026 (updated from August 28, 2025)
✦
Agency: FDA
✦
Company: Green Lumber Holding, LLC
✦
Product: Green Lumber dietary supplement (counterfeit product)
✦
Issue: Undeclared prescription drug – tadalafil
✦
Product details: Dietary supplement blister packs, Lot Number LOT308EXP03/28
✦
Consumer action: Discontinue use immediately and discard the product; report to FDA MedWatch
✦
Stick around to find out more about this recall.
What happened?
The FDA said Green Lumber initiated the recall after agency testing detected tadalafil in products labeled as Green Lumber supplements. The company told regulators it became aware of the issue during an internal investigation following the FDA’s Enforcement Report published on February 9, 2026.
In its recall alert, the FDA warned that “tadalafil is a prescription-only medication and is not an ingredient in any authentic Green Lumber product.” The agency said consumers who take nitrates or certain heart medications face a heightened risk of dangerously low blood pressure and serious adverse events.
The company announced the recall in coordination with the FDA after it discovered that a former employee misappropriated legitimate packaging and customer information to distribute counterfeit or adulterated products. The company has terminated that employee.
Affected products
Brand | Product | Best by date | Issue | Affected states |
|---|---|---|---|---|
Green Lumber | Dietary supplement | 03/28 | Undeclared tadalafil | Nationwide |
What caused the issue?
According to the FDA notice, the problem stems from counterfeit products falsely labeled as Green Lumber supplements that contained tadalafil. The agency confirmed that authentic Green Lumber products do not include this ingredient.
Health risks include low blood pressure, headaches, dizziness, and potentially life-threatening interactions for people with heart disease or those taking nitrates. No confirmed illnesses have been reported so far, but regulators say the risk remains significant.
Questions you might have
A counterfeit Green Lumber dietary supplement labeled with Lot Number LOT308EXP03/28 is being recalled due to undeclared tadalafil.
Tadalafil is a prescription drug that can cause serious side effects, especially when taken without medical supervision.
People with heart disease or those taking nitrates or blood pressure medications face the highest risk.
The FDA detected tadalafil during product testing and reported the findings to the company.
No. Only counterfeit products with the recalled lot number are included.
The FDA has not confirmed any illnesses linked to this recall so far.
Check the lot number on the blister pack or packaging for LOT308EXP03/28.
Stop using it immediately and discard it, or follow the return instructions from the company.
Yes, seek medical advice if you experience symptoms like dizziness, chest pain, or low blood pressure.
Contact Green Lumber directly or submit a report to the FDA’s MedWatch Adverse Event Reporting Program.
Here’s what you should do
- Do not consume products labeled with Lot Number LOT308EXP03/28.
- Check the lot number printed on the blister pack or outer packaging.
- Discard the recalled product or return it if instructed by the retailer.
- Contact Green Lumber with questions or refund requests:
- Phone: 949-426-8622
- Email: [email protected]
Behind the brand
Green Lumber Holding, LLC is a California-based dietary supplement company that markets wellness products directly to consumers. In a statement, company president Brett Hales said, “Consumer safety is our number one priority. We acted swiftly after the FDA’s testing identified tadalafil in a product labeled as ours.”
The company stated it has strengthened internal safeguards and is cooperating with the FDA and law enforcement.
Other relevant recalls
Recent similar recalls tracked by Source86 include dietary supplements pulled for undeclared sildenafil, the Ashfiat Alharamain recall over hidden tadalafil ingredient, tainted weight-loss products, and mislabeled herbal capsules, underscoring that mislabeling and counterfeit goods remain a growing challenge.
Eran Mizrahi, CEO of Source86, added:
“Food safety isn’t just about compliance; it’s about trust. Every recall reminds us how vital transparency and supplier accountability really are.”
Broader pattern
This recall is part of a wider trend of FDA enforcement actions involving supplements with hidden pharmaceutical ingredients. Regulators continue to warn consumers that products claiming sexual enhancement or rapid results are especially vulnerable to adulteration.
Ensuring safe eats
Recalls like this highlight the importance of strict quality controls and traceability across the supply chain. Consumers should remain alert to FDA announcements and verify lot numbers before using supplements.
At Source86, we help food and supplement brands manage ingredient sourcing, oversee FSQA programs, and run private label production with transparency and precision, ensuring supply chains can respond quickly when recalls occur. Contact us.









